A New Method to Induce Myasthenia Gravis Models and the Protective Effect of Soluble Decay Accelerating Factors

Genetics and Molecular Research - Brazil
doi 10.4238/2015.july.14.4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Genetics and Molecular Research

Related search

Markedly Enhanced Susceptibility to Experimental Autoimmune Myasthenia Gravis in the Absence of Decay-Accelerating Factor Protection

Journal of Clinical Investigation
Medicine
2002English

Myasthenia Gravis

CMAJ
Medicine
2018English

Myasthenia Gravis

Postgraduate Medical Journal
Medicine
1965English

Myasthenia Gravis

Seminars in Neurology
Neurology
2016English

Myasthenia Gravis

JAMA - Journal of the American Medical Association
Medicine
2005English

New Approaches to Targeting B Cells for Myasthenia Gravis Therapy

Frontiers in Immunology
AllergyImmunology
2020English

Thymectomy and Myasthenia Gravis.

BMJ
1965English

Pathogenesis of Myasthenia Gravis: Update on Disease Types, Models, and Mechanisms

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

Neonatal Myasthenia Gravis

BMJ
1964English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy